Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Collarbone pseudofractures, also called Looser zones, are narrow bands of unmineralized osteoid that appear on imaging as radiolucent lines running perpendicular to the cortex, and when they show up symmetrically in both clavicles they point strongly toward osteomalacia rather than true trauma. That mirror-image pattern matters because real fractures rarely occur in identical locations on both sides at once, so bilateral microcracks in the clavicles, pubic rami, ribs, or femoral necks signal a systemic mineralization defect from severe vitamin D deficiency, phosphate wasting, kidney disease, malabsorption, or long-term anticonvulsant use. Confirmation usually pairs the imaging findings with labs showing low vitamin D, low or normal calcium and phosphate, elevated alkaline phosphatase, and raised PTH, alongside symptoms like deep aching bone pain, proximal muscle weakness, and a waddling gait. There are several important distinctions between pseudofractures, stress fractures, and metastatic lesions, plus treatment details that change based on the underlying cause, so see below to understand more before drawing conclusions.
Because bone pain and weakness overlap across dozens of conditions, from simple vitamin D insufficiency to hormonal and kidney disorders, the fastest way to organize your symptoms into a useful conversation with a clinician is to run a free, instant, online symptom check and see which possibilities actually fit your pattern.
Last reviewed for medical accuracy: 08/18/2026
Osteomalacia is a bone-softening disorder in adults, most often caused by vitamin D deficiency. One hallmark finding on imaging is the presence of pseudofractures (Looser zones), which are not true breaks but rather microcracks in weakened bone. When these pseudofractures appear symmetrically, especially in the medial third of each clavicle, they strongly point toward osteomalacia. This article explains how these “symmetrical clavicle Looser zones medial third” lesions develop, how they are identified, and what they mean for diagnosis and management.
Osteomalacia literally means “soft bones.” In adults, it results from defective bone mineralization, most commonly due to inadequate vitamin D. The key features include:
Pseudofractures are narrow, radiolucent lines that represent microcracks in the osteoid-rich, undermineralized bone. Unlike true fractures, they:
The medial third of the clavicle is a high‐stress zone where the bone must resist forces from the sternoclavicular joint and support the shoulder girdle. In osteomalacia:
Radiologists and clinicians look for these clues:
Magnetic resonance imaging (MRI) or bone scans can show increased uptake at these sites, but plain X-rays often suffice for detection.
Identifying symmetrical clavicle pseudofractures is more than a radiology curiosity. It guides:
Once imaging raises suspicion, confirm with lab studies:
Additional tests may include kidney and liver function panels, and celiac or other malabsorption screens if indicated.
It’s natural to worry when told you have “soft bones” or “microcracks” in your collarbones. However:
If you’re experiencing any of the symptoms mentioned—bone pain, muscle weakness, or unexplained fatigue—you may want to try a free, online symptom check, using the doctor approved Ubie Symptom Checker to get initial guidance on potential causes.
Always remember: if you suspect a serious problem or experience sudden, severe pain, swelling or difficulty using your bones or muscles, speak to a doctor right away. Regular follow-up and clear communication with a healthcare provider ensure the best outcomes for bone health.
(References)
* Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.
* Böckmann I, Haffner D. The Diagnosis and Therapy of XLH. Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w. Epub 2025 Apr 28. PMID: 40295317; PMCID: PMC12037658.
* Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Laurent MR, Harvengt P, Mortier GR, Böckenhauer D. X-Linked Hypophosphatemia. 1993. PMID: 22319799.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO, AXLES 1 Investigators. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26. PMID: 29947083.
* Seefried L, Rak D, Genest F. Grading Pseudofractures-The "Breach-Beak-Bump-Bridge" Approach. Calcif Tissue Int. 2025 Apr 16;116(1):62. doi: 10.1007/s00223-025-01371-z. Epub 2025 Apr 16. PMID: 40240537; PMCID: PMC12003480.
* Khan AA, Rush ET, Wakeford C, Staub D, Brandi ML. Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval. Adv Ther. 2025 Sep;42(9):4270-4299. doi: 10.1007/s12325-025-03309-1. Epub 2025 Jul 25. PMID: 40715944; PMCID: PMC12394269.
* Ryan PJ, Fogelman I. Bone scintigraphy in metabolic bone disease. Semin Nucl Med. 1997 Jul;27(3):291-305. doi: 10.1016/s0001-2998(97)80030-x. PMID: 9224668.
* Munoz J, Michel Ortega R, Celzo F, Donthireddy V. 'Tumour-induced osteomalacia'. BMJ Case Rep. 2012 Jun 25;2012. doi: 10.1136/bcr.03.2012.5975. Epub 2012 Jun 25. PMID: 22736784; PMCID: PMC3448346.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.